SHC1 and breast carcinoma: Moreover, mammary carcinoma cells that express a mutant ShcA lacking a functional phosphoTyr-binding PTB domain show increased expression of mesenchymal fibronectin and α5β1 integrin [75], arguing that with impaired ShcA function the carcinoma cells might transition toward a mesenchymal phenotype.